Nephrogenic systemic fibrosis is a recently recognized disease entity that is potentially
debilitating. The exact pathogenesis of nephrogenic systemic fibrosis is unclear, but the …

OBJECTIVE. The purpose of this article is to discuss nephrogenic systemic fibrosis (NSF) in
detail regarding its history, possible pathophysiology, clinical and pathologic presentations …

Abstract Purpose of Review Nephrogenic systemic fibrosis (NSF) is a rare systemic disease
with a high mortality. The purpose of this review is to provide clinicians with guidance …

Nephrogenic systemic fibrosis (NSF) is a newly recognized disorder occurring exclusively in
patients with renal failure. Exposure to gadolinium-based magnetic resonance (MR) contrast …

Nephrogenic systemic fibrosis is a progressive, potentially fatal, multiorgan‐system fibrosing
disease related to exposure of patients with renal failure to gadolinium‐based contrast …

The recent and rapid emergence of nephrogenic systemic fibrosis (NSF), a systemic
fibrosing disorder in patients with renal failure, has been a subject of extreme interest and …

Nephrogenic systemic fibrosis is a systemic disorder characterized by widespread tissue
fibrosis. Gadolinium‐based contrast (GBC) was recently noted as a possible trigger for this …

Background and objectives: Nephrogenic systemic fibrosis (NSF) is a disorder that can affect
patients with renal dysfunction exposed to a gadolinium-based contrast agent (GBCA) …

Gadolinium-based contrast agents (GBCAs) used in magnetic resonance imaging are vital
in providing enhanced quality images, essential for diagnosis and treatment. Nephrogenic …

Discovery of an association between gadolinium-based contrast agents (GBCAs) and
nephrogenic systemic fibrosis (NSF) has led to less use of GBCA-enhanced magnetic …